Hyperscalers are investing $1.1 trillion in AI data centers by 2027, requiring extraordinary productivity gains to justify costs. OpenAI is funding efforts to create high-quality scientific datasets from failed biotech companies to advance medical AI breakthroughs.
Montana passed SB535, a biotech law allowing physicians to administer experimental treatments outside trials if they completed FDA Phase 1, received approval from a state review board, and are delivered at licensed clinics with enhanced consent. The law uniquely permits sponsors and clinics to charge for treatment, addressing the "Valley of Death" funding gap where promising drugs stall between early trials and commercial investment.
Social media discussion of AI infrastructure investment trends, including posts about emerging opportunities in AI agents, tokenized assets, and decentralized computing, alongside portfolio commentary on concentrated positions in cleantech, AI infrastructure, and commodities, with reference to Anthropic's substantial compute spending commitments.
Newly released Department of Justice files reveal Jeffrey Epstein's obsession with blue eyes as a marker of intelligence and genetic superiority, reflecting eugenic and race science ideologies he shared with prominent tech leaders and scientists. Epstein funded research into designer babies, human cloning, and artificial intelligence while cultivating relationships with figures in Silicon Valley, universities, and biotech fields who discussed similar ideas about human engineering and population control.
MIT Technology Review's 35 Innovators Under 35 list highlights nine biotech researchers transforming the field. Featured innovators include Paschal Kija, who developed an affordable device to prevent maternal deaths; Xiao Yang, creating flexible brain electrodes inspired by Japanese kirigami art; Sarah Grandinette, who designed personalized gene-editing therapy for a rare genetic disorder; Yuancheng Lu, reversing aging-related vision loss; and Samuel King, using AI to design new bacteriophages for potential medical applications.